Found: 38
Select item for more details and to access through your institution.
Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-1866-2
- By:
- Publication type:
- Article
Worldwide post‐marketing safety surveillance experience with tofacitinib in ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 3, p. 302, doi. 10.1111/apt.16619
- By:
- Publication type:
- Article
Comparison of Newly Diagnosed Ocular Hypertension and Open-Angle Glaucoma: Ocular Variables, Risk Factors, and Disease Severity.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Comparison of Newly Diagnosed Ocular Hypertension and Open-Angle Glaucoma: Ocular Variables, Risk Factors, and Disease Severity.
- Published in:
- Journal of Ophthalmology, 2012, p. 1, doi. 10.1155/2012/757106
- By:
- Publication type:
- Article
A retrospective, pooled data analysis of the safety of pegaptanib sodium in the treatment of age-related macular degeneration in subjects with or without diabetes mellitus.
- Published in:
- BMC Ophthalmology, 2012, v. 12, n. 1, p. 37, doi. 10.1186/1471-2415-12-37
- By:
- Publication type:
- Article
Dopaminergic Polymorphisms Associated with Time-on-Task Declines and Fatigue in the Psychomotor Vigilance Test.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0033767
- By:
- Publication type:
- Article
Tofacitinib in the treatment of Indian patients with rheumatoid arthritis: A post hoc analysis of efficacy and safety in Phase 3 and long‐term extension studies over 7 years.
- Published in:
- International Journal of Rheumatic Diseases, 2020, v. 23, n. 7, p. 882, doi. 10.1111/1756-185X.13853
- By:
- Publication type:
- Article
Efficacy and safety of tofacitinib for the treatment of rheumatoid arthritis in patients from the Asia‐Pacific region: Post‐hoc analyses of pooled clinical study data.
- Published in:
- International Journal of Rheumatic Diseases, 2019, v. 22, n. 6, p. 1094, doi. 10.1111/1756-185X.13516
- By:
- Publication type:
- Article
Tofacitinib with conventional synthetic disease‐modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient‐reported outcomes from a Phase 3 randomized controlled trial.
- Published in:
- International Journal of Rheumatic Diseases, 2018, v. 21, n. 2, p. 402, doi. 10.1111/1756-185X.13244
- By:
- Publication type:
- Article
Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel).
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 4, p. 1045, doi. 10.1007/s10067-021-05908-z
- By:
- Publication type:
- Article
Lymphoma in the Tofacitinib Rheumatoid Arthritis Clinical Development Program.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) Versus ASDAS: A Post Hoc Analysis of a Randomized Controlled Trial.
- Published in:
- Journal of Rheumatology, 2022, v. 40, n. 10, p. 1100, doi. 10.3899/jrheum.211075
- By:
- Publication type:
- Article
Impact of Tofacitinib on Components of the ACR Response Criteria: Post Hoc Analysis of Phase III and Phase IIIb/IV Trials.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III Studies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Assessment of radiographic progression in patients with rheumatoid arthritis treated with tofacitinib in long-term studies.
- Published in:
- Rheumatology, 2021, v. 60, n. 4, p. 1708, doi. 10.1093/rheumatology/keaa476
- By:
- Publication type:
- Article
Analysis of haematological changes in tofacitinib-treated patients with rheumatoid arthritis across phase 3 and long-term extension studies.
- Published in:
- Rheumatology, 2017, v. 56, n. 1, p. 46, doi. 10.1093/rheumatology/kew329
- By:
- Publication type:
- Article
Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials.
- Published in:
- Digestive Diseases & Sciences, 2021, v. 66, n. 8, p. 2732, doi. 10.1007/s10620-020-06560-4
- By:
- Publication type:
- Article
Multi-detector CT/CT angiogram assessment of acute pancreatic graft dysfunction.
- Published in:
- Journal of Medical Imaging & Radiation Oncology, 2011, v. 55, n. 6, p. 571, doi. 10.1111/j.1754-9485.2011.02314.x
- By:
- Publication type:
- Article
A 12-week, randomized, double-masked study of fixed combination latanoprost/timolol versus latanoprost or timolol monotherapy.
- Published in:
- European Journal of Ophthalmology, 2010, v. 20, n. 4, p. 708, doi. 10.1177/112067211002000411
- By:
- Publication type:
- Article
Analysis of Infections and All-Cause Mortality in Phase II, Phase III, and Long-Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, n. 11, p. 2924, doi. 10.1002/art.38779
- By:
- Publication type:
- Article
Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials.
- Published in:
- Arthritis Research & Therapy, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13075-023-03154-z
- By:
- Publication type:
- Article
Joint-level responses to tofacitinib and methotrexate: a post hoc analysis of data from ORAL Start.
- Published in:
- Arthritis Research & Therapy, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13075-023-03144-1
- By:
- Publication type:
- Article
Relationship between lymphocyte count and risk of infection in Japanese rheumatoid arthritis patients treated with tofacitinib.
- Published in:
- Modern Rheumatology, 2024, v. 34, n. 6, p. 1115, doi. 10.1093/mr/roae030
- By:
- Publication type:
- Article
Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 5, p. 1135, doi. 10.1007/s40744-024-00677-y
- By:
- Publication type:
- Article
Long-term Etanercept Response for Patients with Radiographic Axial Spondyloarthritis Based on Achievement of Early, Intermediate, or Late Responses During Index Studies.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 583, doi. 10.1007/s40744-024-00656-3
- By:
- Publication type:
- Article
Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 5, p. 1255, doi. 10.1007/s40744-023-00576-8
- By:
- Publication type:
- Article
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 2, p. 357, doi. 10.1007/s40744-022-00507-z
- By:
- Publication type:
- Article
Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 1, p. 243, doi. 10.1007/s40744-021-00390-0
- By:
- Publication type:
- Article
Long-Term Radiographic and Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Treated with Tofacitinib: ORAL Start and ORAL Scan Post-hoc Analyses.
- Published in:
- Rheumatology & Therapy, 2018, v. 5, n. 2, p. 341, doi. 10.1007/s40744-018-0113-7
- By:
- Publication type:
- Article
Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population.
- Published in:
- Rheumatology & Therapy, 2018, v. 5, n. 2, p. 383, doi. 10.1007/s40744-018-0118-2
- By:
- Publication type:
- Article
Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2023, p. 1, doi. 10.1177/1759720X221149965
- By:
- Publication type:
- Article
Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2023, v. 15, p. 1, doi. 10.1177/1759720X221149965
- By:
- Publication type:
- Article
Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 11, p. 1761, doi. 10.1093/ecco-jcc/jjad104
- By:
- Publication type:
- Article
Cognitive Workload Assessment Based on the Tensorial Treatment of EEG Estimates of Cross-Frequency Phase Interactions.
- Published in:
- Annals of Biomedical Engineering, 2015, v. 43, n. 4, p. 977, doi. 10.1007/s10439-014-1143-0
- By:
- Publication type:
- Article
Discriminative Analysis of Brain Functional Connectivity Patterns for Mental Fatigue Classification.
- Published in:
- Annals of Biomedical Engineering, 2014, v. 42, n. 10, p. 2084, doi. 10.1007/s10439-014-1059-8
- By:
- Publication type:
- Article
The Effects of Varying Break Length on Attention and Time on Task.
- Published in:
- 2016
- By:
- Publication type:
- journal article